GC–MS analysis, pharmacokinetic properties, molecular docking and dynamics simulation of bioactives from Curcumis maderaspatanus to target oral cancer-Reference-Cited by-同舟云学术

GC–MS analysis, pharmacokinetic properties, molecular docking and dynamics simulation of bioactives from Curcumis maderaspatanus to target oral cancer

Published:2024-03-11 Issue:1 Volume:12 Page:
ISSN:2193-9616
Container-title:In Silico Pharmacology
language:en
Short-container-title:In Silico Pharmacol.

Author:

Rao Ronisha Shankar,Saravanan Deepak,Mohan Monisha

Funder

DST SERB, Government of India

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s40203-023-00177-x.pdf

Reference31 articles.

1. Abraham MJ, Murtola T, Schulz R, Páll S, Smith JC, Hess B et al (2015) GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 1–2:19–25

2. Araki-Maeda H, Kawabe M, Omori Y, Yamanegi K, Yoshida K, Yoshikawa K et al (2022) Establishment of an oral squamous cell carcinoma cell line expressing vascular endothelial growth factor a and its two receptors. J Dent Sci 17:1471–1479

3. Bavetsias V, Large JM, Sun C, Bouloc N, Kosmopoulou M, Matteucci M et al (2010) Imidazo[4,5-b]pyridine derivatives as inhibitors of Aurora kinases: lead optimization studies toward the identification of an orally bioavailable preclinical development candidate. J Med Chem 53:5213–5228

4. Chen X, Zhang F-H, Chen Q-E, Wang Y-Y, Wang Y-L, He J-C et al (2015) The clinical significance of CDK1 expression in oral squamous cell carcinoma. Med Oral Patol Oral Cir Bucal 20:e7-12

5. Choudhari AS, Mandave PC, Deshpande M, Ranjekar P, Prakash O (2019) Phytochemicals in cancer treatment: from preclinical studies to clinical practice. Front Pharmacol 10:1614